vs

Side-by-side financial comparison of ASIA PACIFIC WIRE & CABLE CORP LTD (APWC) and Ascendis Pharma A/S (ASND). Click either name above to swap in a different company.

Ascendis Pharma A/S is the larger business by last-quarter revenue ($267.3M vs $225.3M, roughly 1.2× ASIA PACIFIC WIRE & CABLE CORP LTD).

Disney Networks Group Asia Pacific was a Hong Kong–based commercial broadcasting company operating multiple specialty television channels. The company was founded in 1991 by Hong Kong - Canadian businessman Richard Li.

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

APWC vs ASND — Head-to-Head

Bigger by revenue
ASND
ASND
1.2× larger
ASND
$267.3M
$225.3M
APWC

Income Statement — Q2 FY2022 vs Q4 FY2025

Metric
APWC
APWC
ASND
ASND
Revenue
$225.3M
$267.3M
Net Profit
Gross Margin
7.9%
90.5%
Operating Margin
2.2%
Net Margin
Revenue YoY
42.3%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APWC
APWC
ASND
ASND
Q4 25
$267.3M
Q3 25
$230.7M
Q2 25
$170.7M
Q1 25
$109.0M
Q4 24
$187.8M
Q3 24
$62.5M
Q2 24
$38.9M
Q1 24
$103.6M
Net Profit
APWC
APWC
ASND
ASND
Q4 25
Q3 25
$-65.9M
Q2 25
$-42.0M
Q1 25
$-102.2M
Q4 24
Q3 24
$-107.1M
Q2 24
$-118.1M
Q1 24
$-141.5M
Gross Margin
APWC
APWC
ASND
ASND
Q4 25
90.5%
Q3 25
89.5%
Q2 25
80.1%
Q1 25
82.6%
Q4 24
91.9%
Q3 24
80.6%
Q2 24
68.2%
Q1 24
92.1%
Operating Margin
APWC
APWC
ASND
ASND
Q4 25
Q3 25
5.1%
Q2 25
-33.5%
Q1 25
-103.2%
Q4 24
Q3 24
-167.3%
Q2 24
-370.2%
Q1 24
-51.2%
Net Margin
APWC
APWC
ASND
ASND
Q4 25
Q3 25
-28.5%
Q2 25
-24.6%
Q1 25
-93.7%
Q4 24
Q3 24
-171.5%
Q2 24
-303.9%
Q1 24
-136.6%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APWC
APWC
ASND
ASND
Cash + ST InvestmentsLiquidity on hand
$665.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-175.8M
Total Assets
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APWC
APWC
ASND
ASND
Q4 25
$665.3M
Q3 25
$582.2M
Q2 25
$533.6M
Q1 25
$559.4M
Q4 24
$604.3M
Q3 24
$675.6M
Q2 24
$279.4M
Q1 24
$345.9M
Stockholders' Equity
APWC
APWC
ASND
ASND
Q4 25
$-175.8M
Q3 25
$-188.0M
Q2 25
$-202.6M
Q1 25
$-205.0M
Q4 24
$-114.2M
Q3 24
$-105.1M
Q2 24
$-346.8M
Q1 24
$-257.2M
Total Assets
APWC
APWC
ASND
ASND
Q4 25
$1.4B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.1B
Q4 24
$1.3B
Q3 24
$1.2B
Q2 24
$819.0M
Q1 24
$866.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APWC
APWC
ASND
ASND
Operating Cash FlowLast quarter
$58.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APWC
APWC
ASND
ASND
Q4 25
$58.2M
Q3 25
Q2 25
Q1 25
$-15.5M
Q4 24
$-330.7M
Q3 24
Q2 24
Q1 24
$-109.7M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons